SunAct Cancer Institute and CytoMed begin phase 2 trials for Gamma Delta T-cell therapy

Watchdoq January 9, 2025

Collaborative trials aim to advance affordable cancer treatment for solid tumours in India
The post SunAct Cancer Institute and CytoMed begin phase 2 trials for Gamma Delta T-cell therapy appeared first on Express Healthcare.

Read Full Article